Skip to content

Clinical trials

Phase 1 Mesothelioma, Malignant trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Mesothelioma, Malignant Phase: Phase 1 Clear all

81 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20002
20012
20021
20033
20041
20064
20073
20081
20092
20102
20112
20121
20142
20155
20162
20173
20183
20198
20205
20215
20223
20234
20246
20251
20264

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed39
Recruiting12
Terminated11
Active, not recruiting7
Unknown status6
Withdrawn5
Not yet recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
National Cancer Institute (NCI)11
Memorial Sloan Kettering Cancer Center7
M.D. Anderson Cancer Center6
Abramson Cancer Center at Penn Medicine3
Erasmus Medical Center3
University of Pennsylvania3
Mayo Clinic2
National Institutes of Health Clinical Center (CC)2
Roswell Park Cancer Institute2
University of Chicago2

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Mesothelioma, Malignant81
Carcinoma, Non-Small-Cell Lung26
Lung Neoplasms13
Ovarian Neoplasms13
Mesothelioma12
Pancreatic Neoplasms11
Neoplasms10
Carcinoma, Ovarian Epithelial9
Esophageal Neoplasms9
Uterine Cervical Neoplasms9

Trials

Showing 1 to 25 of 81. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.